RDY | tickerfilter.com

Fundamental analysis

47%

Profitability 46%

Dept financing 16%

Liquidity 53%

Performance 55%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.59%

1 Month

3.52%

3 Months

20.18%

6 Months

8.91%

1 Year

22.11%

2 Year

62.61%

Key data

Stock price

$83.47

P/E Ratio

0.00

DAY RANGE

$82.96 - $83.56

EPS

$0.00

52 WEEK RANGE

$63.35 - $84.46

52 WEEK CHANGE

$0.23

MARKET CAP

13.933 B

YIELD

0.57%

SHARES OUTSTANDING

166.923 M

DIVIDEND

$0.4792

EX-DIVIDEND DATE

07/30/2024

NEXT EARNINGS DATE

10/24/2024

BETA

0.27

PUBLIC FLOAT

AVERAGE 10 VOLUME

$149,931

AVERAGE 30 VOLUME

$193,194

Company detail

CEO: G. Prasad
Region: US
Website: http://www.drreddys.com/
Employees: 24,795
IPO year: -

Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

They are an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.

RDY - Dr. Reddy`s Laboratories Ltd. - ADR